Advertisement
ResearchIn-Press PreviewCell biologyImmunology
Open Access |
10.1172/JCI199108
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Wang, H. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Jiang, H. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by He, S. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Ren, S. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Li, H. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Liu, W. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Zhou, C. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Zhu, P. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Chen, K. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Cao, W. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Qin, Y. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Du, D. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Xiao, N. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Huang, H. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by
Ko, C.
in:
PubMed
|
Google Scholar
|
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Zheng, Y. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Wang, B. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Zou, Q. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by
Shi, J.
in:
PubMed
|
Google Scholar
|
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Li, X. in: PubMed | Google Scholar
1Department of Oncology, School of Life Sciences, Xiamen University, Xiamen, China
2Department of Laboratory Medicine, School of Medicine, Xiamen University, Xiamen, China
3Central Laboratory, Hebei Collaborative Innovation Center of Tumor Microeco, Clinical Medical College, Hebei University, Hebei, China
4School of Public Health, Xiamen University, Xiamen, China
5Department of Stomatology, Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Find articles by Jie, Z. in: PubMed | Google Scholar
Published April 23, 2026 - More info
Type 1 conventional dendritic cells (cDC1s) play an integral role in mediating immune responses and maintaining homeostasis, yet the molecular mechanisms underlying their functions remain poorly understood. In this study, we identified dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) as a key kinase that responded to TLR and growth factor stimulation and acted as an essential regulator of cDC1 function. Genetic ablation of Dyrk1a specifically in cDC1s impaired antitumor immunity and accelerated tumor progression in murine models. Mechanistically, DYRK1A mediated the phosphorylation of the mTORC1 inhibitor TSC2 at serine 540, triggering the degradation of TSC2 and promoting the mTORC1 signaling in cDC1s. Notably, Tsc2 deletion in Dyrk1a-deficient cDC1s remarkably restored their antitumor immune functions. Furthermore, DYRK1A-mediated mTORC1 signaling in cDC1s positively correlated with effector T-cell responses across multiple human cancers. Our findings highlight a critical role for the DYRK1A-TSC2-mTORC1 signaling pathway in regulating cDC1 functions in antitumor immunity, offering potential strategies to improve cancer immunotherapy.